Brødkrumme Forside Spero Therapeutics Spero Therapeutics Spero has a pipeline of novel treatments for multi-drug resistant (MDR) bacterial infections. Two programs are in clinical phase I Spero Therapeutics website Lundbeckfonden BioCapital Investeringsår 2015 IPO in 2017 – SPRO (Nasdaq) Lokation Boston, Massachusetts, USA